Preliminary scientific tests reveal conolidine might inhibit specific ion channels, lessening neuronal excitability and restricting discomfort indicators. This mechanism is particularly suitable in neuropathic agony, wherever abnormal signaling causes persistent soreness. Additionally, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to agony perception... https://moshei395dul1.bloggazza.com/profile